Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Conclusions
Among a national cohort of PDAC survivors and caregivers, the majority preferred SF for resectable PDAC, whereas NT was preferred when the resectability of a tumor was in question. The impact of NT on quantity and quality of life, as well as the likelihood of achieving surgical resection, was most highly valued by participants.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Borderline Tumor | Cancer | Cancer & Oncology | Carbohydrates | Gastroenterology | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer